COLLEGIUM PHARMACEUTICAL INC (COLL)
US19459J1043 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 238.95M | 173.70M | 186.40M | 174.10M | 170.00M | |||
| Marketable Securities | 71.60M | N/A | N/A | N/A | N/A | |||
| Receivables | 179.53M | 183.10M | 105.80M | 83.30M | 73.00M | |||
| Inventories | 32.33M | 46.50M | 17.40M | 15.60M | 9.60M | |||
| Other Current Assets | 15.20M | 16.70M | 5.90M | 4.90M | 3.10M | |||
| Total Current Assets | 537.60M | 420.00M | 315.50M | 277.90M | 255.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 22.01M | 26.40M | 27.10M | 27.40M | 20.90M | |||
| Goodwill | 133.86M | 133.70M | N/A | N/A | N/A | |||
| Intangibles | 421.71M | 567.50M | 268.70M | 335.90M | 29.50M | |||
| Other Non-Current Assets | 28.13M | 26.60M | 80.70M | 2.70M | 200.00K | |||
| Total Non-Current Assets | 605.71M | 754.10M | 376.60M | 365.90M | 50.60M | |||
| TOTAL ASSETS | 1.14B | 1.17B | 692.10M | 643.80M | 306.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 183.33M | 162.50M | 48.40M | 47.50M | 3.80M | |||
| Accrued Expenses | 258.74M | 263.40M | 223.80M | 180.10M | 191.70M | |||
| Accounts Payable | 8.69M | 3.50M | 4.20M | 10.00M | 6.20M | |||
| Other Current Liabilities | 7.15M | 4.40M | 3.20M | 1.80M | N/A | |||
| Total Current Liabilities | 457.92M | 433.70M | 279.60M | 239.50M | 201.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 483.84M | 538.50M | 201.60M | 209.60M | 7.70M | |||
| Other Non-Current Liabilities | 6.12M | 7.10M | 8.00M | 8.80M | 9.40M | |||
| Total Non-Current Liabilities | 489.96M | 545.60M | 209.50M | 218.30M | 17.10M | |||
| TOTAL LIABILITIES | 947.88M | 979.30M | 489.10M | 457.80M | 218.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -233.19M | -281.30M | -256.30M | -333.10M | -359.90M | |||
| Additional Paid In Capital | 565.95M | 538.10M | 502.10M | 519.10M | 447.30M | |||
| Common Shares | 38.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -137.38M | -61.90M | -42.90M | N/A | N/A | |||
| Other Shareholders' Equity | 14.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 31.87M | 33.80M | 33.70M | 34.60M | 33.70M | |||
| Tangible Book Value per Share | -11.30 | -14.98 | -1.95 | -4.33 | 1.72 | |||
| Total Shareholders' Equity | 195.43M | 194.80M | 202.90M | 186.00M | 87.40M | |||
| TOTAL LIABILITIES AND EQUITY | 1.14B | 1.17B | 692.10M | 643.80M | 306.30M | |||
| Statistics | ||||||||
| Debt/Equity | 2.48 | 2.76 | 0.99 | 1.13 | 0.09 | |||
| Current Ratio | 1.17 | 0.97 | 1.13 | 1.16 | 1.27 | |||
| Return On Assets (ROA) | 4.21% | -2.13% | 10.33% | 4.16% | -7.41% | |||
| Return On Equity (ROE) | 24.64% | -12.83% | 35.24% | 14.41% | -25.97% | |||
| Return On Invested Capital (ROIC) | 16.28% | 5.96% | 3.87% | 8.84% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 29.76% | 7.79% | 7.06% | 15.52% | N/A | |||
All data in USD